SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-317289
Filing Date
2013-08-02
Accepted
2013-08-02 16:47:59
Documents
3
Period of Report
2013-07-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d578518d8k.htm 8-K 16524
2 EX-99.1 d578518dex991.htm EX-99.1 10094
3 GRAPHIC g578518g34w87.jpg GRAPHIC 26000
  Complete submission text file 0001193125-13-317289.txt   64117
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 131006929
SIC: 3841 Surgical & Medical Instruments & Apparatus